Global Bioabsorbable Stents Market Size and Forecast 2023-2032 Abbott Laboratories, REVA Medical Inc., Elixir Medical Corporation, Biotronik SE & Co. KG, Amaranth Medical Inc.

The Bioabsorbable Stents Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2011-2022) and extends its insights into a ten-year forecast period (2024-2033)

Learn More On The Bioabsorbable Stents Market:

https://www.thebusinessresearchcompany.com/report/bioabsorbable-stents-global-market-report

According to The Business Research Company’s Bioabsorbable Stents Global Market Report 2024, The bioabsorbable stents market size has grown rapidly in recent years. It will grow from $0.35 billion in 2023 to $0.38 billion in 2024 at a compound annual growth rate (CAGR) of 10.7%. The growth in the historic period can be attributed to rising prevalence of cardiovascular diseases, growing demand for minimally invasive procedures, increasing awareness of bioabsorbable stents, rising disposable incomes, industry investments.

The bioabsorbable stents market size is expected to see strong growth in the next few years. It will grow to $0.55 billion in 2028 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to expanded clinical indications, customization and personalization, global expansion, patient-friendly option. Major trends in the forecast period include advancements in bioabsorbable materials, clinical advancements, clinical data and research, hybrid stent designs, longer absorption periods, collaborations and partnerships.

Increasing cardiovascular diseases is a key factor driving the growth of the bioabsorbable stents market. Cardiovascular disorders are the leading cause of death across the world and 4 out of 5 cardiovascular deaths are caused by strokes and heart attacks. Moreover, one-third of such deaths occur prematurely in people under the age of 70. Bioresorbable stents are built primarily to reduce these risks of late complications, such as scaffold thrombosis or restenosis, that can happen when a conventional metal stent’s rigid metal backbone remains permanently rooted in the diseased vessel. According to the American Heart Association, it is estimated that more than 23.6 million die due to cardiovascular diseases by 2030. Therefore, increasing cardiovascular diseases are expected to drive the bioabsorbable stents industry.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample_request?id=3269&type=smp

The bioabsorbable stents market covered in this report is segmented –

1) By Product Type: Polymer-based Bioabsorbable Stents; Metal-based Bioabsorbable Stents

2) By Absorption Rate: Slow- absorption stents; Fast- absorption Stents

3) By Applications: Coronary Artery Diseases; Peripheral Artery Diseases

The bioabsorbable stents market report table of contents includes:

1. Executive Summary

2. Bioabsorbable Stents Market Characteristics

3. Bioabsorbable Stents Market Trends And Strategies

4. Bioabsorbable Stents Market – Macro Economic Scenario

5. Global Bioabsorbable Stents Market Size and Growth